ACHE and early-onset autosomal dominant Alzheimer disease: The primary outcome of this computational analysis suggested that huperzine A likely influences Alzheimer’s disease through various synaptic neurotransmitter and metabolic pathways, rather than through a direct effect on acetylcholinesterase [259].